HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gervasio A Lamas Selected Research

Chelation Therapy (Therapy, Chelation)

4/2024Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
1/2023Contaminant Metals as Cardiovascular Risk Factors: A Scientific Statement From the American Heart Association.
12/2022[Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment].
12/2022Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment.
1/2022Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
11/2020Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients.
1/2020Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT).
1/2020Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings.
1/2019The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
1/2018Chelation therapy to prevent diabetes-associated cardiovascular events.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gervasio A Lamas Research Topics

Disease

43Myocardial Infarction
12/2022 - 07/2004
25Infarction (Infarctions)
06/2014 - 11/2004
19Heart Failure
01/2023 - 06/2003
16Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 07/2004
9Atherosclerosis
01/2021 - 10/2002
7Stroke (Strokes)
01/2023 - 07/2004
4Peripheral Arterial Disease
01/2023 - 01/2019
4Sick Sinus Syndrome
09/2014 - 06/2003
4Coronary Disease (Coronary Heart Disease)
07/2014 - 10/2002
4Ischemia
04/2009 - 09/2007
4Ventricular Fibrillation
05/2008 - 09/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 03/2012
3Diabetes Mellitus
01/2014 - 07/2004
3Atrial Fibrillation
12/2013 - 06/2003
3Hypertension (High Blood Pressure)
03/2012 - 10/2002
3Reperfusion Injury
11/2008 - 09/2007
3Left Ventricular Dysfunction
11/2004 - 06/2004
2Hemorrhage
01/2023 - 08/2011
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 01/2008
2Mitral Valve Insufficiency (Mitral Regurgitation)
01/2013 - 08/2005
2Aortic Valve Stenosis (Aortic Stenosis)
06/2012 - 01/2012
2Asphyxia (Suffocation)
11/2008 - 04/2008
2Heart Arrest (Cardiac Arrest)
04/2008 - 01/2002
2Cardiomyopathies (Cardiomyopathy)
11/2002 - 07/2002
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024
1Venous Thromboembolism
01/2023
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2023
1Pathologic Constriction (Stenosis)
01/2023
1COVID-19
01/2023
1Isolated Systolic Hypertension
01/2016
1Prehypertension
01/2016
1Heart Block
06/2015
1Heart Diseases (Heart Disease)
05/2015
1Atrioventricular Block
09/2014
1Sepsis (Septicemia)
05/2014
1Endocarditis
05/2014
1Chronic Renal Insufficiency
12/2013
1Acute Kidney Injury (Acute Renal Failure)
12/2013
1Non-ST Elevated Myocardial Infarction
04/2013
1Chronic Obstructive Pulmonary Disease (COPD)
10/2012
1Renal Insufficiency (Renal Failure)
10/2012
1Thrombosis (Thrombus)
04/2012
1Respiratory Sounds (Crackle)
03/2012

Drug/Important Bio-Agent (IBA)

9Edetic Acid (EDTA)FDA Link
04/2024 - 03/2013
9MetalsIBA
01/2023 - 06/2012
8CadmiumIBA
01/2023 - 12/2014
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2024 - 09/2005
4CreatinineIBA
07/2014 - 10/2012
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2012 - 06/2004
3Insulin (Novolin)FDA Link
04/2024 - 11/2004
3Captopril (Capoten)FDA LinkGeneric
11/2004 - 07/2004
2Environmental Pollutants (Pollutants, Environmental)IBA
01/2023 - 12/2014
2ArsenicIBA
01/2023 - 12/2014
2SolutionsIBA
10/2022 - 07/2014
2Chelating AgentsIBA
01/2022 - 12/2014
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 10/2002
2XenobioticsIBA
12/2014 - 08/2014
2Indicators and Reagents (Reagents)IBA
10/2012 - 05/2005
2ProstaglandinsIBA
05/2008 - 01/2008
2Angiotensin Receptor AntagonistsIBA
09/2005 - 11/2004
2LipidsIBA
10/2004 - 10/2002
2Brain Natriuretic Peptide (Natrecor)FDA Link
11/2002 - 07/2002
1Sodium-Glucose Transporter 2 InhibitorsIBA
04/2024
1Warfarin (Coumadin)FDA LinkGeneric
04/2024
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2024
1apixabanIBA
01/2023
1Acetic Acid (Vinegar)FDA LinkGeneric
10/2022
1MineralsIBA
10/2022
1ethylenediamine (ethylenediamine dihydroiodide)FDA Link
10/2022
1Divalent CationsIBA
01/2022
1CalciumIBA
01/2022
1AcidsIBA
01/2018
1ethyleneIBA
01/2018
1Advanced Glycation End ProductsIBA
01/2018
1DiaminesIBA
01/2018
1VitaminsIBA
01/2018
1salicylhydroxamic acid (SHAM)IBA
01/2016
1Heavy MetalsIBA
01/2016
1MercuryIBA
12/2014
1Dichlorodiphenyldichloroethane (DDD)IBA
09/2014
1SmokeIBA
03/2012

Therapy/Procedure

32Therapeutics
01/2020 - 10/2002
25Percutaneous Coronary Intervention
06/2014 - 12/2006
22Chelation Therapy (Therapy, Chelation)
04/2024 - 03/2013
5Sternotomy
05/2014 - 06/2011
5Cardiopulmonary Resuscitation (CPR)
05/2008 - 01/2002
4Length of Stay
05/2014 - 11/2010
3Secondary Prevention
12/2016 - 12/2014
3Stents
06/2012 - 09/2009
2Drug Therapy (Chemotherapy)
01/2021 - 08/2005
2Patient Readmission
11/2010 - 11/2008
2Resuscitation
11/2008 - 04/2008
2Induced Heart Arrest (Cardioplegia)
04/2008 - 01/2008
1Contraindications
01/2023
1Spinal Manipulation
01/2016
1Cardiac Resynchronization Therapy
06/2015
1Off-Label Use
09/2014
1Minimally Invasive Surgical Procedures
12/2013
1Thoracotomy
01/2013
1Drug-Eluting Stents
06/2012